ЭМБЕРИ Клэр Луис (GB),ЭДВАРДС Кристофер Дэвид (GB)
申请号：
RU2013157398/15
公开号：
RU2013157398A
申请日:
2012.07.19
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. A pharmaceutical dosage form containing compound (I) or a pharmaceutically acceptable salt thereof and a means for preparing a metered dose of compound (I) or a pharmaceutically acceptable salt thereof. The pharmaceutical dosage form according to claim 1, providing from 0.5 nanograms to 20 micrograms of compound (I) for bringing the dosage agent into action. 3. The pharmaceutical dosage form according to claim 2, providing from 0.5 nanograms to 5 micrograms for bringing the dosage agent into action. The pharmaceutical dosage form according to claim 3, providing from 1 nanogram to 5 micrograms for bringing the dosage agent into action. The pharmaceutical dosage form according to claim 4, providing from 0.5 nanograms to 999 nanograms for bringing the dosage agent into action. The pharmaceutical dosage form according to claim 5, providing from 1 nanogram to 999 nanograms for bringing the dosage agent into action. A pharmaceutical composition comprising a compound (I) or a pharmaceutically acceptable salt thereof, characterized in that the pharmaceutical composition is suitable for use with a dosing agent. Compound (I) or a pharmaceutically acceptable salt thereof for use in the treatment of allergic diseases and other inflammatory conditions, for example, allergic rhinitis and allergic asthma, characterized in that from 0.5 nanograms to 40,000 nanograms of compound (I) is administered to a person in need thereof. 9 . Compound (I) or a pharmaceutically acceptable salt thereof for use according to claim 8, wherein from 1 nanogram to 20,000 nanograms of compound (I) is administered to a person in need thereof. Compound (I) or a pharmaceutically acceptable salt thereof1. Фармацевтическая лекарственная форма, содержащая соединение (I) или его фармацевтически приемлемую соль и средство для получения отмеренной дозы соединения (I) или его фармацевтически приемлемой соли.2. Фармацевтическая лекарственная форма по п. 1, обеспечивающая от 0,5 нанограмм до 20 микрограмм соедин
